Is glycaemic control still central in the hierarchy of priorities in type 2 diabetes management? The way forward is to combine glucose control and the prevention of cardiorenal complications Antonio CerielloFrancesco PrattichizzoCesare Berra Letter 04 October 2024
Addressing disparities in the long-term mortality risk in individuals with non-ST segment myocardial infarction (NSTEMI) by diabetes mellitus status: a nationwide cohort study Andrew ColeNicholas WeightMamas A. Mamas Article Open access 03 October 2024
Publisher Correction: EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary European Association for the Study of the LiverEuropean Association for the Study of DiabetesEuropean Association for the Study of Obesity Publisher Correction Open access 01 October 2024
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers Lue Ping ZhaoGeorge K. PapadopoulosÅke Lernmark Article Open access 01 October 2024
Oxidised phosphatidylcholine induces sarcolemmal ceramide accumulation and insulin resistance in skeletal muscle Karin A. Zemski BerryAmanda GarfieldBryan C. Bergman Article 30 September 2024
Identification of proteins associated with type 2 diabetes risk in diverse racial and ethnic populations Shuai LiuJingjing ZhuLang Wu Extended Article 30 September 2024
Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study Sapna SharmaQiuling DongHarald Grallert Article Open access 30 September 2024
Mortality rates in people presenting with a new diabetes-related foot ulcer: a cohort study with implications for management Naomi HolmanArthur C. YellandFran Game Article Open access 27 September 2024
A whole-food, plant-based intensive lifestyle intervention improves glycaemic control and reduces medications in individuals with type 2 diabetes: a randomised controlled trial Cody J. HanickCourtney M. PetersonJohn H. Kelly Jr. Article Open access 21 September 2024
The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial Nancy S. ElbarbaryEman A. IsmailAmal A. Elkholy Article Open access 14 September 2024
Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study Astrid LavensChristophe De Blockon behalf of the IQED Group of Experts Article Open access 13 September 2024
Risk factors for Charcot foot development in individuals with diabetes mellitus Georgios TsatsarisNeda Rajamand EkbergSergiu-Bogdan Catrina Article Open access 13 September 2024
Genetic evidence for efficacy of targeting IL-2, IL-6 and TYK2 signalling in the prevention of type 1 diabetes: a Mendelian randomisation study Tea E. HeikkiläEmilia K. KaiserVille Karhunen Article Open access 13 September 2024
60th EASD Annual Meeting of the European Association for the Study of Diabetes Abstracts 12 September 2024
Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease Rodolfo J. GalindoDiana SolimanConnie M. Rhee Correction Open access 10 September 2024 Pages: 2371 - 2371
The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity Nathalie EsserMeghan F. HoganSteven E. Kahn Article Open access 09 September 2024 Pages: 1897 - 1911
An antifibrotic compound that ameliorates hyperglycaemia and fat accumulation in cell and HFD mouse models Tsugumasa TomaNobukazu MiyakawaHiroshi Tateishi Article 09 September 2024
Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes Sigurd Lenzen Letter Open access 07 September 2024
Lifetime history of gestational diabetes and cognitive function in parous women in midlife Diana C. Soria-ContrerasSiwen WangJorge E. Chavarro Article 06 September 2024
Implicating type 2 diabetes effector genes in relevant metabolic cellular models using promoter-focused Capture-C Nicholas A. WachowskiJames A. PippinMatthew C. Pahl Article Open access 06 September 2024
Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes. Reply to Lenzen S [letter] Decio L. EizirikPriscila L. ZimathSarah J. Richardson Letter 05 September 2024
Similar early metabolic changes induced by dietary weight loss or bariatric surgery. Reply to Taylor R [letter] Jan W. ErikssonMaria J. PereiraHåkan Ahlström Letter 05 September 2024
Similar early metabolic changes induced by dietary weight loss or bariatric surgery Roy Taylor Letter 05 September 2024
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes Moshe PhillipPeter AchenbachLinda A. DiMeglio Correction Open access 04 September 2024 Pages: 2012 - 2014
Dietary patterns during pregnancy and maternal and birth outcomes in women with type 1 diabetes: the Environmental Determinants of Islet Autoimmunity (ENDIA) study Rebecca L. ThomsonJames D. Brownon behalf of the ENDIA Study Group Article Open access 02 September 2024
Metformin and small for gestational age babies: findings of a randomised placebo-controlled clinical trial of metformin in gestational diabetes (EMERGE) Fidelma DunneChristine NewmanAndrew Smyth Short Communication Open access 31 August 2024
Global experiences and personal narratives on diabetes technology and access Renza ScibiliaNiki Breslin-BrookerJurgen Vercauteren Letter 30 August 2024 Pages: 2027 - 2033
The future is here: an overview of technology in diabetes Ritwika MallikPartha KarAnna Krook Editorial 30 August 2024 Pages: 2019 - 2026
Effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease Donna S.-H. LinJen-Kuang LeeHao-Yun Lo Article 29 August 2024
Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases Lianna W. WatKatrin J. Svensson REVIEW 24 August 2024
Genetics of glucose homeostasis in pregnancy and postpartum William L. Lowe JrAlan KuangDenise M. Scholtens Article 24 August 2024
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care Gian Paolo FadiniEnrico Longatoon behalf of DARWIN-Renal Study Investigators Article Open access 23 August 2024
Machine learning-based reproducible prediction of type 2 diabetes subtypes Hayato TanabeMasahiro SatoMichio Shimabukuro Article Open access 21 August 2024
Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management Kamlesh KhuntiFrancesco ZaccardiJuliana C. N. Chan For Debate Open access 19 August 2024
Reduced type 2 diabetes incidence reflecting end of post‑World War II calorie restrictions in Germany. Reply to Nilsson PM, Vaag A [letter] Carolin T. LehnerGunther SchaubergerStefanie J. Klug Letter Open access 17 August 2024 Pages: 2369 - 2370
Reduced type 2 diabetes incidence reflecting end of post-World War II calorie restrictions in Germany Peter M. NilssonAllan Vaag Letter 15 August 2024 Pages: 2367 - 2368
Applying technologies to simplify strategies for exercise in type 1 diabetes Bruce A. PerkinsLauren V. TurnerMichael C. Riddell Review 15 August 2024 Pages: 2045 - 2058
Genetic relations between type 1 diabetes, coronary artery disease and leukocyte counts Jolade AdebekunAjay NadigDavid A. Alagpulinsa Article 14 August 2024
Ageing well with diabetes: the role of technology Giuseppe MalteseSybil A. McAuleyAlan J. Sinclair Review Open access 13 August 2024 Pages: 2085 - 2102
Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes Kieran SmithGuy S. TaylorDaniel J. West Article Open access 13 August 2024
Accuracy of continuous glucose monitoring in the hospital setting: an observational study Mollie Y. O’ConnorKristen L. FlintMelissa S. Putman Article 10 August 2024
Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management Aikaterini EleftheriadouVincenza SpalloneUazman Alam Review Open access 09 August 2024
Diabetes technology in people with diabetes and advanced chronic kidney disease Rodolfo J. GalindoDiana SolimanConnie M. Rhee Review Open access 08 August 2024 Pages: 2129 - 2142
Scientists and scientific journals should adhere to ethical standards for the use and reporting of data from Indigenous people Joseph YrachetaTaylor MorriseauJonathan McGavock For Debate 06 August 2024
Mortality risk for kidney transplant candidates with diabetes: a population cohort study Raja RashidDaoud ChaudhryAdnan Sharif Article Open access 06 August 2024
Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study Isabel HurtadoCelia RoblesGabriel Sanfélix-Gimeno Article Open access 06 August 2024
Whole-exome and whole-genome sequencing of 1064 individuals with type 1 diabetes reveals novel genes for diabetic kidney disease Jani K. HaukkaAnni A. Antikainenon behalf of the FinnDiane Study Group Article Open access 06 August 2024
Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis Lu YouLauric A. Ferratthe Type 1 Diabetes TrialNet Study Group Article 06 August 2024
